GAMP Data Integrity 21 CFR Part 11 Training Course

Why Should You Attend:

The importance and amount of data being generated to ensure product quality and patient safety continues to grow, and proper controls around that data continue to be a subject of regulatory scrutiny. Regulatory agencies across the world are repeatedly citing data integrity issues. As a result, industry guidance and enforcement strategies are evolving. Regulatory concerns and warning letters have extended to all areas of the pharmaceutical, biotech, and medical device business, including manufacturing, development, clinical, pharmacovigilance and other areas of the product lifecycle

Areas Covered in the Webinar:

This training course will provide a practical understanding of the following:

• The current regulatory focus on Data Integrity, including a detailed discussion of US 21 CFR 11
• Relevant regulatory observations
• Current regulatory?Guidance on Data Integrity (emphasizing MHRA and FDA)
• The need for Data integrity throughout the system and data life cycles
• Detailed examination of the data life cycle
• The requirement for a data governance framework
• A data integrity maturity model
• How to meet the international regulatory requirements for electronic records and signatures
• Detailed examination of specific requirements of 21 CFR 11 electronic records and signatures
• How to satisfy Part 11, including interpretation of the FDA Scope and Application Guidance
• How to meet the requirements of other relevant regulations including EU Annex 11
• How to apply the current industry risk-based good practice approach to compliant electronic records and signatures
• How to maintain Data Integrity through the GAMP system life cycle and beyond
• How cloud computing approaches can impact data integrity
• Data integrity and mobile apps
• Data mapping as an important tool in ensuring data integrity
• How to apply the new ISPE GAMP® Guide:?Records and Data Integrity including:
• Data Governance Framework
• Culture and Human Factors
• Data Life Cycle
• Applying Quality Risk Management to Data Integrity

Who Will Benefit:

• All those working in a GxP regulated environment that require a working knowledge of data integrity, electronic records and signatures, and the associated operational aspects of GxP computerized systems.
• Anyone who needs a fundamental understanding of the 21 CFR Part 11 regulation and risk management approaches to achieving electronic record and signature compliance.
• Computer system vendors or consultants, engineering contractors, and validation service companies.
• Quality assurance and quality control specialists, validation specialists, manufacturing supervisors, technical support personnel, engineers, MIS professionals and all levels of management who need a fundamental understanding of computerized system compliance and regulations.

Kelly Thomas
Head Of Quality Assurance, Veru Inc

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk-based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

Follow us :